company background image
DVYSR

Devyser Diagnostics OM:DVYSR Stock Report

Last Price

kr68.41

Market Cap

kr1.1b

7D

-7.2%

1Y

n/a

Updated

01 Dec, 2022

Data

Company Financials +
DVYSR fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

DVYSR Stock Overview

Devyser Diagnostics AB (publ) provides diagnostic kits for DNA testing within hereditary diseases, oncology, and transplantation.

Devyser Diagnostics AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Devyser Diagnostics
Historical stock prices
Current Share Pricekr68.41
52 Week Highkr100.00
52 Week Lowkr56.10
Beta0
1 Month Change13.90%
3 Month Change3.67%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-23.14%

Recent News & Updates

Recent updates

Devyser Diagnostics AB (publ) (STO:DVYSR) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

May 14
Devyser Diagnostics AB (publ) (STO:DVYSR) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Shareholder Returns

DVYSRSE BiotechsSE Market
7D-7.2%0.4%-1.1%
1Yn/a-25.2%-23.8%

Return vs Industry: Insufficient data to determine how DVYSR performed against the Swedish Biotechs industry.

Return vs Market: Insufficient data to determine how DVYSR performed against the Swedish Market.

Price Volatility

Is DVYSR's price volatile compared to industry and market?
DVYSR volatility
DVYSR Average Weekly Movement12.4%
Biotechs Industry Average Movement8.3%
Market Average Movement7.3%
10% most volatile stocks in SE Market12.4%
10% least volatile stocks in SE Market4.5%

Stable Share Price: DVYSR is more volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: DVYSR's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
200487Fredrik Alpstenhttps://www.devyser.com

Devyser Diagnostics AB (publ) provides diagnostic kits for DNA testing within hereditary diseases, oncology, and transplantation. The company offers products in the areas of transplantation, thalassemia, oncology, fetal RHD screening non-invasive prenatal testing, hereditary, cystic fibrosis, cardiovascular, male infertility, and rapid aneuploidy analysis, as well as accessories. Its products are used to guide targeted cancer therapies, to enable rapid prenatal diagnostics, and in post-transplant follow-up.

Devyser Diagnostics AB (publ) Fundamentals Summary

How do Devyser Diagnostics's earnings and revenue compare to its market cap?
DVYSR fundamental statistics
Market Capkr1.09b
Earnings (TTM)-kr39.93m
Revenue (TTM)kr116.88m

9.4x

P/S Ratio

-27.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DVYSR income statement (TTM)
Revenuekr116.88m
Cost of Revenuekr22.27m
Gross Profitkr94.61m
Other Expenseskr134.54m
Earnings-kr39.93m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 21, 2023

Earnings per share (EPS)-2.49
Gross Margin80.95%
Net Profit Margin-34.16%
Debt/Equity Ratio0.2%

How did DVYSR perform over the long term?

See historical performance and comparison